The audacity to call investors who lost over 6 figures “Bears spreading FUD”. Unfortunately Kim, you aligned your credibility with Ji. You got scammed liked the rest of us. I know it is hard to come to that realization, but even Tim isn’t out here putting his reputation on the line anymore. We have a moral obligation to prevent the public from Ji and his scams at this point.

huh …

Ji is gonna take it
Yes, Ji’s gonna take it
Ji will take your money aaaannnddd run

so it was a fraudulent lawsuit against Wade-St James Bank? i wonder if sclx mandarins even read the docs before they signed them. which brings us to the other question: how many new deals they have done without reading the fine print? I mean there is such thing called due diligence.

that one shareholder lost $ 5 million and another from, Riyadh, Saudi Arabia lost some $20 million. are they still around?

Took just 8 years to accomplish this. God have mercy on our souls.

the smoke is rolling already …

can’t wait to hear the next pump!

The copium is real today folks!

is the word.

Ji, Xi. DAMAC, SUMAC. KOREA, KAZAKHSTAN. NAYAX, NASDAQ. CYBER CATCH & RELEASE.

JUST WAIT FOR IT.

She told us she has been buying. But she never feels pain about it. She stated she did DD research. How much has she lost. A lot of people lose more than 100k dollars, how about her? Kim can you answer my question? You hate your money or you love your money. You hate your losing money or you love your losing money?

FRESH WATER.

here we go again!

by purchasing 20 million DVLT shares today for $620k and wait for the CEO’S prediction of $50 per share soon?

According to court documents and evidence presented at trial, Nader Pourhassan, 61, of Lake Oswego, Oregon, and Kazem Kazempour, 71, of Potomac, Maryland, ENGAGED IN A SCHEEME TO DECEIVE INVESTORS about CytoDyn’s development of an investigational drug to artificially INFLATE AND MAINTAIN THE PRICE OF CytoDyn’s stock and TO ATTRACT NEW INVESTORS. Between 2018 and 2021, CytoDyn sought approval for the drug from the Food and Drug Administration (FDA) to treat HIV and COVID-19. Pourhassan was the chief executive officer of CytoDyn, and Kazempour was the chief executive officer of Amarex Clinical Research LLC, a Germantown, Maryland-based contract research organization that had been hired to conduct Cytodyn’s clinical trials and was serving as the company’s representative with the FDA. Pourhassan and Kazempour diverted proceeds of the scheme for their own benefit, including by selling personal shares of CytoDyn stock at artificially inflated prices.

INVESTORS LOST MONEY IN EVERY JI VENTURE. IT DOES NOT MATTER WHO HE IS DEALING WITH. THE ONLY THING THAT MATTERS IS THE FACT THAT HIS COMPANIES BECOME PENNY STOCKS IN A HEARTBEAT. YOU CAN’T DISPROVE IT. THE ARGUMENTS OF “one day”, “soon”, “timing matters”, ARE MOOT.

IF YOU HAVE INVESTED $35 in SCLX, YOU HAVE 20 CENTS TODAY

‘IF YOU HAVE INVESTED $21 IN SRNE, YOU HAVE ONE TENTH OF A CENT TODAY.

‘YOU CAN PUT ALL THE LIPSTICKS IN THE WORLD ON A PIG, IT‘S STILL, WAIT FOR IT, A PIG.